about
The Economic Costs of Type 2 Diabetes: A Global Systematic ReviewDisparities in recommended preventive care usage among persons living with diabetes in the Appalachian regionThe Hospitalization Costs of Diabetes and Hypertension Complications in Zimbabwe: Estimations and Correlations.Slow-wave sleep and the risk of type 2 diabetes in humans.Zinc supplementation in pre-diabetes: study protocol for a randomized controlled trial.Comorbidity in patients with diabetes mellitus: impact on medical health care utilizationPharmacoeconomic evaluation of diabetic nephropathic patients attending nephrology department in a tertiary care hospital.Healthcare costs associated with progressive diabetic retinopathy among National Health Insurance enrollees in Taiwan, 2000-2004.Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban ChinaThe cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study.What works in community-based interventions promoting physical activity and healthy eating? A review of reviews.Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetes.Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore.Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitusThe economics of diabetes prevention.Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study.Factors associated with consulting a dietitian for diabetes management: a cross-sectional studyMedical costs associated with type 2 diabetes complications and comorbidities.Costs of diabetes mellitus in KoreaCoDE: Community Diabetes Education for uninsured Mexican Americans.Better together: a community- hospital integrative model of healthcare as a practical solution for providing excellence in endocrinology care in an era of limited resources.The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from KoreaThe prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.Direct medical costs for patients with type 2 diabetes and related complications: a prospective cohort study based on the Korean National Diabetes Program.Patterns and Determinants of Complementary and Alternative Medicine Practitioner Use among Adults with Diabetes in Queensland, AustraliaOut-Of-Pocket Expenditures on Complementary Health Approaches Associated With Painful Health Conditions in a Nationally Representative Adult Sample.The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers.Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002-2011.Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).The relationship between age and healthcare expenditure among persons with diabetes mellitus.Health care costs in people with diabetes and their association with glycemic control and kidney function.Economic costs of diabetes in Saudi ArabiaThe Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective StudyCost-effectiveness of treating resistant hypertension with an implantable carotid body stimulatorThe effects of quality of care on costs: a conceptual frameworkNationally representative medical costs of diabetes by time since diagnosis.Medical costs of CKD in the Medicare population
P2860
Q28087120-C424AE9B-70E1-43DB-BB67-2A1CAF036EF6Q30275029-118C499A-16EC-43FA-8BEE-FC680422ED05Q30382904-1D078F31-41C6-4ECC-B7A4-6DB22E3FDACCQ30481284-0CCF0CD1-C29C-43D5-AEC6-4CC1D0082821Q30537731-705C54EA-4367-4CE5-A34C-69795FD45A25Q33248806-A4A21FA7-99E4-4837-A8DC-1304023F43FEQ33573338-52E5F203-07FB-48EB-9A3B-A43E72597D4DQ33586935-1D2860C2-9B19-4013-93C4-801CB8879A6FQ33667465-0D6D5F26-BBB0-45E4-9C0D-0600D2423F30Q33801995-E7DFB993-A2A7-453A-AEF3-C5DF37960B74Q33833875-D932D14D-6386-4695-925D-C42DAB4B1A72Q33873025-2E6B7EAA-4860-48B3-9824-BB89D1163998Q33897885-A17D32C4-F4EB-4711-9A7B-9911DF425F99Q34024171-3EC4FFBC-D0D4-473A-9A5C-08B9A6B81C43Q34700621-7D08C13E-1A05-449F-9E89-72AB97B4E3A8Q34728128-9A1BAE81-FD40-49BF-9AC5-96A52707C085Q35059113-D69FBDE0-47CF-4B94-8D17-68272668829BQ35110549-C5BE9A12-9A72-409C-B28C-37ABDDD9BA73Q35661417-CD17D215-7637-496A-8ECE-E685302D1A7EQ35744974-25C6D638-4253-4210-B5A4-9DBABF48AFECQ35807198-6B47600A-A91D-4A16-9BA3-4887A282A14AQ35841138-88765A13-5A7B-435B-885A-5D424CCCDE0EQ35877943-D9742600-5ED1-4908-BE02-3EAE1ECE9128Q35956522-9F6A9457-0C21-4A44-840B-D48C0B1D0A5DQ36014734-E90852DB-C8EA-4C5E-BE6A-69671802A9E7Q36134577-539DF01A-0663-4DAD-B697-B26A1469CD4CQ36167462-1DF4F549-F825-4A14-A64A-8C999A599ED6Q36240352-C7E8EC4A-0024-4367-AB21-CFD9B947C764Q36295307-B6B428DA-A8D1-4671-8472-51A8100EE796Q36343865-C020BA04-0C4D-4DE7-A32D-BBA5D1265384Q36423515-8CBC4C3D-55A9-4690-8998-D577500B882FQ36572736-B8EA6F4B-6019-4317-9F4C-A9CD67EA1DF4Q36681317-4D77688D-E977-4C08-B0C4-13187D22AAEFQ36782623-7906E9AE-101A-4B83-9DD4-17AD14E1715CQ36872613-46AB84CC-FA38-4A7B-A733-72E4EE48A085Q36915588-739762EE-DB5D-4DF5-83D1-85FDCC031A7FQ36949147-C8E30988-764D-435A-978A-7659EC0FF8A0Q36965504-61925565-9293-4AB9-9B4E-324D9B8D2441Q36975684-09812806-26A7-47EC-973C-67178053587CQ37119893-12B525F0-7C22-4065-B4CA-63E4B6930160
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The direct medical cost of type 2 diabetes.
@en
The direct medical cost of type 2 diabetes.
@nl
type
label
The direct medical cost of type 2 diabetes.
@en
The direct medical cost of type 2 diabetes.
@nl
prefLabel
The direct medical cost of type 2 diabetes.
@en
The direct medical cost of type 2 diabetes.
@nl
P2093
P1433
P1476
The direct medical cost of type 2 diabetes.
@en
P2093
Bahman P Tabaei
Barbara R K Smith
Deanna Marriott
Honghong Zhou
Michael Brandle
Morton B Brown
William H Herman
P304
P356
10.2337/DIACARE.26.8.2300
P407
P577
2003-08-01T00:00:00Z